Here, we demonstrate that Bixin is a potent activator of AMPK and that AMPK is required for the activation of the PERK/eIF-2α/ATF4 pathway induced by Bixin or by its combination with TRAIL in CRC cells. This evidence concerns the gene EIF2A and colorectal carcinoma.